Good for Business, Investments, Latvia, Real Estate
International Internet Magazine. Baltic States news & analytics
Friday, 04.07.2025, 07:24
Hili Ventures to renovate Dole shopping mall in three years

![]() |
---|
He said that purchase of Dole shopping mall in early 2019 was a good business opportunity.
"Dole was built many years ago and changes are necessary," he said, adding that renovation works might start soon and should be completed in three years.
"It is a large shopping center, therefore there will be much work. Its floor space is 16,000 m2, but currently only 8,000 m2 are used," he said.
Asked whether Hili Ventures plans to purchase another shopping center in Latvia or elsewhere, Hili said that the company already owns several shopping centers in the Baltics and some of them are being developed.
As reported, Maltese-based property investment company Hili Properties completed acquisition of Dole shopping mall in Riga in early 2019.
Premier Estates LTD, a company associated with restaurant chain McDonald's, a sister company of Hili Properties, acquired Tirdzniecibas Centrs Dole, the sole owner and developer of the Dole shopping mall in Riga.
Previously Norwegian company AMD Holding was the sole owner of Tirdzniecibas Centrs Dole.
- 28.01.2022 BONO aims at a billion!
- 26.08.2021 LLC Dizozols Investments finalizes investment attraction deal with Crowdestor with record-high profits
- 13.02.2021 Моя жизнь в газете. Очерки по новейшей истории Латвии. Глава 1
- 25.01.2021 Как банкиры 90-х делили «золотую милю» в Юрмале
- 30.12.2020 Накануне 25-летия Балтийский курс/The Baltic Course уходит с рынка деловых СМИ
- 30.12.2020 On the verge of its 25th anniversary, The Baltic Course leaves business media market
- 30.12.2020 Business Education Plus предлагает анонсы бизнес-обучений в январе-феврале 2021 года
- 30.12.2020 Hotels showing strong interest in providing self-isolation service
- 30.12.2020 EU to buy additional 100 mln doses of coronavirus vaccine
- 30.12.2020 ЕС закупит 100 млн. дополнительных доз вакцины Biontech и Pfizer